Aneurysmal subarachnoid haemorrhages (aSAH) account for 5% of strokes and continues to place a great burden on patients and their families. Cerebral vasospasm (CVS) is one of the main causes of death after aSAH, and is usually diagnosed between day 3 and 14 after bleeding. Its pathogenesis remains poorly understood. To verify whether plasma concentration of amino acids have prognostic value in predicting CVS, we analysed data from 35 patients after aSAH (median age 55 years, IQR 39–62; 20 females, 57.1%), and 37 healthy volunteers (median age 50 years, IQR 38–56; 19 females, 51.4%). Fasting peripheral blood samples were collected on postoperative day one and seven. High performance liquid chromatography-mass spectrometry (HPLC-MS) analysis ...
Aneurysmal subarachnoid hemorrhage (aSAH) is associated with high rates of mortality and morbidity. ...
International audiencePURPOSE: The aim of this study was to determine if the measurement of blood bi...
BACKGROUND: There remains a proportion of patients with unfavorable outcomes after aneurysmal subara...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Biomarkers for neurodegeneration could be early prognostic measures of brain damage and dysfunction ...
Delayed cerebral vasospasm (CVS) and delayed cerebral ischemia (DCI) remain severe complications aft...
Objective: Clinicopathological studies on patients succumbing to subarachnoid haemorrhage (SAH) demo...
Cerebral vasospasm (CVS) is a major contributor to the high morbidity and mortality of aneurysmal su...
Object: Aneurysmal subarachnoid hemorrhage (aSAH) is a common cause of death or long-term disability...
Background: Protein S100B has proven to be a useful biomarker for cerebral damages. Increased levels...
Aim: The interest of inflammatory marker increased in the last years, even in preventing clinical ou...
Even though survival is considerably enhanced after surgical treatment of an aneurysmal subarachnoid...
BackgroundVasospasm and other secondary neurological insults may follow subarachnoid haemorrhage (SA...
Aneurysmal subarachnoid haemorrhage (aSAH) is a devastating form of stroke associated with significa...
Biomarkers for the prediction of vasospasm and delayed cerebral ischemia in patients with a ruptured...
Aneurysmal subarachnoid hemorrhage (aSAH) is associated with high rates of mortality and morbidity. ...
International audiencePURPOSE: The aim of this study was to determine if the measurement of blood bi...
BACKGROUND: There remains a proportion of patients with unfavorable outcomes after aneurysmal subara...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Biomarkers for neurodegeneration could be early prognostic measures of brain damage and dysfunction ...
Delayed cerebral vasospasm (CVS) and delayed cerebral ischemia (DCI) remain severe complications aft...
Objective: Clinicopathological studies on patients succumbing to subarachnoid haemorrhage (SAH) demo...
Cerebral vasospasm (CVS) is a major contributor to the high morbidity and mortality of aneurysmal su...
Object: Aneurysmal subarachnoid hemorrhage (aSAH) is a common cause of death or long-term disability...
Background: Protein S100B has proven to be a useful biomarker for cerebral damages. Increased levels...
Aim: The interest of inflammatory marker increased in the last years, even in preventing clinical ou...
Even though survival is considerably enhanced after surgical treatment of an aneurysmal subarachnoid...
BackgroundVasospasm and other secondary neurological insults may follow subarachnoid haemorrhage (SA...
Aneurysmal subarachnoid haemorrhage (aSAH) is a devastating form of stroke associated with significa...
Biomarkers for the prediction of vasospasm and delayed cerebral ischemia in patients with a ruptured...
Aneurysmal subarachnoid hemorrhage (aSAH) is associated with high rates of mortality and morbidity. ...
International audiencePURPOSE: The aim of this study was to determine if the measurement of blood bi...
BACKGROUND: There remains a proportion of patients with unfavorable outcomes after aneurysmal subara...